Non Hodgkin Lymphoma Clinical Trial

Clinical Trial Finder Non Hodgkin Lymphoma Trials

Investigation of the Cylex® ImmuKnow® Assay

See Locations Near You

Summary

Currently, there is no accurate way of predicting the occurrence of Graft vs Host Disease (GvHD) or infection. The purpose of this study is to analyze blood with the ImmuKnow® Assay to see if doctors can detect which patients are at risk for GvHD and for getting an infection before they occur.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients who are undergoing allogeneic HSCT using a myeloablative preparative regimen for any of the following disorders are eligible:

Acute leukemia
Non-Hodgkin's Lymphoma
Chronic lymphocytic leukemia
Hodgkin's disease
Multiple myeloma
Myelodysplastic Syndromes
Myeloproliferative Disorders
Aplastic Anemia
Chronic myelogenous leukemia

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

45

Study ID:

NCT00569842

Recruitment Status:

Completed

Sponsor:

Indiana University School of Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Indiana Universtiy Simon Cancer Center
Indianapolis Indiana, 46202, United States

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

45

Study ID:

NCT00569842

Recruitment Status:

Completed

Sponsor:


Indiana University School of Medicine

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Clinical Trials Test State-of-the-Art Cancer Treatments
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider